Neil Stahl - Dec 3, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Research and Development
Signature
/s/**Neil Stahl
Stock symbol
REGN
Transactions as of
Dec 3, 2021
Transactions value $
-$18,858,197
Form type
4
Date filed
12/6/2021, 03:10 PM
Previous filing
May 18, 2021
Next filing
Dec 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 -4.61 K -13.78% $0.00 28.8 K Nov 29, 2021 Direct
transaction REGN Common Stock Options Exercise $13 M +72.5 K +251.66% $179.13 101 K Dec 3, 2021 Direct
transaction REGN Common Stock Tax liability -$31.8 M -50.4 K -49.7% $632.45 51 K Dec 3, 2021 Direct
transaction REGN Common Stock Gift $0 +4.61 K $0.00 4.61 K Nov 29, 2021 by Spouse as Trustee
holding REGN Common Stock 5.79 K Dec 3, 2021 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -72.5 K -100% $0.00 0 Dec 3, 2021 Common Stock 72.5 K $179.13 Direct F1

Explanation of Responses:

Id Content
F1 The stock option award vests in four equal annual installments, commencing one year after the date of grant.